MedCity News October 20, 2024
Pharmaceutical and biotech companies are using generative AI to predict drug-target interactions, optimize lead compounds, and generate novel molecular structures. During the recent MedCity News INVEST Digital Health conference, a panel discussed these applications and more.
Generative artificial intelligence is finding more uses in the pharmaceutical industry, condensing unstructured information into insight and automating tasks that were one labor intensive. It’s not the solution to everything. But it’s becoming a solution to many things.
“Sometimes people just want to throw new technologies at every problem and think that’s going to work,” said David Latshaw, CEO and co-founder of BioPhy, a life sciences health tech company. “The better way to think about it is with these new capabilities, what can we...
Today's Sponsors
Today's Sponsor